What is the recommended protocol for administering iron dextran (intravenous iron) infusion in a patient with confirmed iron deficiency anemia who cannot tolerate oral iron?

Iron Dextran Infusion Protocol

For patients with confirmed iron deficiency anemia who cannot tolerate oral iron, use low-molecular-weight iron dextran (INFeD) with a mandatory 25 mg test dose given as slow IV push over at least 30 seconds, wait 1 hour, then administer 100 mg IV over 5 minutes weekly for 10 doses to achieve a total of 1000 mg. 1

Critical Safety Considerations

Always use low-molecular-weight iron dextran (INFeD) rather than high-molecular-weight formulations (Dexferrum). Most adverse events, including the historical fatalities (31 deaths reported between 1976-1996), occurred with high-molecular-weight preparations 2. The low-molecular-weight formulation has a significantly better safety profile while maintaining equivalent efficacy 3.

Mandatory Test Dose Protocol

• Administer 25 mg (0.5 mL) slow IV push over at least 30 seconds 1, 4
• Wait minimum 1 hour before proceeding with therapeutic dose 1
• Although anaphylactic reactions typically occur within minutes, the waiting period is essential for safety
• Have resuscitation facilities immediately available 2

Standard Dosing Regimens

For Hemodialysis Patients (In-Center)

• 100 mg IV over 5 minutes, once weekly for 10 weeks (total 1000 mg) 1, 3
• This minimizes dose-related arthralgias and myalgias that occur with higher individual doses 3
• More economical than larger infusions requiring extended monitoring 3

For Non-Dialysis CKD, Home Hemodialysis, or Peritoneal Dialysis Patients

When weekly visits are impractical, 500-1000 mg diluted in 250 mL normal saline infused over 1 hour is reasonable 3. However, patients must be informed about increased incidence of myalgias/arthralgias with these larger doses 3.

Total Dose Calculation

Use the Ganzoni formula 4:

• Dose (mL) = 0.0442 × (Desired Hb - Observed Hb) × LBW + (0.26 × LBW)
• Maximum total dose = 1000 mg initially
• If calculated dose exceeds 1000 mg, give remaining dose after 4 weeks if inadequate hemoglobin response 1

Alternative Formulations to Consider

While iron dextran is effective, newer formulations may offer advantages in specific situations:

Ferric Carboxymaltose or Iron Isomaltoside

• Can deliver up to 1000 mg in a single 15-minute infusion 5, 2
• No test dose required 5, 6
• Preferred when minimizing visits is critical 7
• Similar safety profile to iron dextran, with true anaphylaxis remaining exceedingly rare (<1:200,000 administrations) 8, 7

Iron Sucrose

• 200 mg IV over 60 minutes 1
• No test dose required (though recommended if history of iron dextran sensitivity) 1
• Maximum single dose 200-500 mg 5
• Requires more frequent dosing than newer formulations

Ferric Gluconate

• 125 mg IV over 60 minutes 1
• No test dose required 1
• Individual doses above 125 mg not recommended 1

Absolute Contraindications

• Active infection - do not administer IV iron during active infection 1
• Known hypersensitivity to iron dextran 4
• Anemia not due to iron deficiency 4

Common Pitfalls to Avoid

1. Using high-molecular-weight iron dextran - This formulation has unacceptable toxicity and should never be used 6

2. Skipping the test dose - While newer formulations don't require test doses, iron dextran mandates this safety step 1, 4

3. Administering too rapidly - The 100 mg dose should be given over 5 minutes minimum, not as rapid push 1

4. Inadequate monitoring period - Must observe for at least 1 hour after test dose before proceeding 1

5. Underdosing - Many patients receive less iron than needed; calculate total iron deficit and ensure adequate repletion 9

6. Measuring iron studies too soon - Wait 2-7 days after last dose for accurate ferritin and transferrin saturation measurements (7 days for 100-125 mg doses, 14 days for doses ≥1000 mg) 3

Monitoring and Follow-Up

• Hemoglobin and hematocrit are the primary monitoring parameters 4
• Reticulocyte count increases within days as first sign of response 4
• Ferritin and transferrin saturation should be checked 2-7 days after final dose 3
• Hemoglobin rise at 12 weeks is similar between oral and IV iron, though IV iron produces more rapid initial response 2

Recognition of Infusion Reactions

Most reactions are complement activation-related pseudo-allergy (CARPA), not true anaphylaxis 8, 7. True anaphylaxis is exceedingly rare 8. Common adverse events include hypotension, hypertension, nausea, vomiting, diarrhea, pain, fever, dyspnea, pruritus, headaches, and dizziness 1.

Have resuscitation equipment immediately available for all IV iron administrations 2.